BNGO
Income statement / Annual
Last year (2023), Bionano Genomics, Inc.'s total revenue was $36.12 M,
an increase of 29.90% from the previous year.
In 2023, Bionano Genomics, Inc.'s net income was -$232.49 M.
See Bionano Genomics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$36.12 M
|
$27.80 M
|
$17.98 M
|
$8.50 M
|
$10.13 M
|
$12.00 M
|
$9.51 M
|
$6.79 M
|
| Cost of Revenue |
$26.55 M |
$21.86 M |
$14.11 M |
$5.73 M |
$6.77 M |
$8.71 M |
$6.03 M |
$3.58 M |
| Gross Profit |
$9.57 M |
$5.95 M |
$3.87 M |
$2.77 M |
$3.36 M |
$3.29 M |
$3.47 M |
$3.21 M |
| Gross Profit Ratio |
0.26 |
0.21 |
0.22 |
0.33 |
0.33 |
0.27 |
0.37 |
0.47 |
| Research and Development
Expenses |
$54.03 M
|
$49.05 M
|
$22.49 M
|
$10.26 M
|
$9.08 M
|
$9.48 M
|
$12.01 M
|
$11.43 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14.22 M
|
$14.08 M
|
$12.95 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$94.96 M
|
$88.60 M
|
$58.49 M
|
$31.07 M
|
$20.16 M
|
$14.22 M
|
$14.08 M
|
$12.95 M
|
| Other Expenses |
$75.82 M |
-$223,000.00 |
-$59,000.00 |
-$2.56 M |
-$3.94 M |
-$675,853.00 |
-$289,010.00 |
-$203,285.00 |
| Operating Expenses |
$148.99 M |
$137.64 M |
$80.98 M |
$41.32 M |
$29.24 M |
$23.70 M |
$26.09 M |
$24.38 M |
| Cost And Expenses |
$251.36 M |
$159.50 M |
$95.08 M |
$47.05 M |
$36.00 M |
$32.42 M |
$32.12 M |
$27.96 M |
| Interest Income |
$3.31 M |
$1.51 M |
$236,000.00 |
$2.52 M |
$2.29 M |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$5.12 M |
$298,000.00 |
$927,000.00 |
$2.52 M |
$2.29 M |
$1.38 M |
$590,927.00 |
$470,072.00 |
| Depreciation &
Amortization |
$13.71 M
|
$10.10 M
|
$3.97 M
|
$1.47 M
|
$1.13 M
|
$1.32 M
|
$1.50 M
|
$1.12 M
|
| EBITDA |
-$213.60 M
|
-$120.32 M
|
-$73.86 M
|
-$37.08 M
|
-$26.38 M
|
-$15.78 M
|
-$21.25 M
|
-$17.25 M
|
| EBITDA Ratio |
-5.91 |
-4.69 |
-4.28 |
-4.53 |
-2.55 |
-1.76 |
-2.25 |
-2.98 |
| Operating Income Ratio
|
-5.96
|
-4.74
|
-4.29
|
-4.53
|
-2.55
|
-1.7
|
-2.44
|
-3.12
|
| Total Other
Income/Expenses Net |
-$17.19 M
|
$986,000.00
|
-$1.05 M
|
-$2.53 M
|
-$3.92 M
|
$1.93 M
|
-$128,004.00
|
$2.33 M
|
| Income Before Tax |
-$232.43 M |
-$130.71 M |
-$78.15 M |
-$41.11 M |
-$29.82 M |
-$18.48 M |
-$23.35 M |
-$18.84 M |
| Income Before Tax Ratio
|
-6.44
|
-4.7
|
-4.35
|
-4.83
|
-2.94
|
-1.54
|
-2.46
|
-2.77
|
| Income Tax Expense |
$62,000.00 |
$1.88 M |
-$5.72 M |
$29,193.00 |
$21,048.00 |
$15,511.00 |
$18,552.00 |
$12,924.00 |
| Net Income |
-$232.49 M |
-$132.60 M |
-$72.44 M |
-$41.14 M |
-$29.84 M |
-$18.50 M |
-$23.37 M |
-$18.85 M |
| Net Income Ratio |
-6.44 |
-4.77 |
-4.03 |
-4.84 |
-2.95 |
-1.54 |
-2.46 |
-2.77 |
| EPS |
-6.81 |
-4.58 |
-2.62 |
-3.95 |
-19.92 |
-26.14 |
-86.5 |
-36.06 |
| EPS Diluted |
-6.81 |
-4.58 |
-2.62 |
-3.95 |
-19.92 |
-26.14 |
-86.5 |
-36.06 |
| Weighted Average Shares
Out |
$34.15 M
|
$28.92 M
|
$27.68 M
|
$10.43 M
|
$1.50 M
|
$707,712.00
|
$270,106.00
|
$522,744.00
|
| Weighted Average Shares
Out Diluted |
$34.15 M
|
$28.92 M
|
$27.68 M
|
$10.43 M
|
$1.50 M
|
$707,713.00
|
$270,106.00
|
$522,744.00
|
| Link |
|
|
|
|
|
|
|
|
